Gastric Cancer Therapy Market Size, Trends, Analysis, and Outlook By Disease (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others), By Treatment (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Specialty and Retail Pharmacies, Others, Hospital Pharmacies), by Country, Segment, and Companies, 2024-2032
The global Gastric Cancer Therapy market size is poised to register 16.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gastric Cancer Therapy market across By Disease (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others), By Treatment (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Specialty and Retail Pharmacies, Others, Hospital Pharmacies)
The gastric cancer therapy market is undergoing rapid transformation driven by advancements in oncology research, personalized medicine approaches, and evolving treatment paradigms. Gastric cancer remains a significant global health burden, with high morbidity and mortality rates, necessitating continuous innovation in therapeutic strategies. Emerging treatments such as targeted therapies, immune checkpoint inhibitors, and combination regimens are showing promise in improving survival outcomes and quality of life for patients with advanced or metastatic gastric cancer. Further, the integration of genomic profiling, biomarker testing, and liquid biopsy techniques is facilitating precision oncology approaches, enabling tailored treatment decisions based on individual tumor characteristics and patient factors. Additionally, the emphasis on multidisciplinary care, supportive therapies, and patient-centric approaches is driving the development of holistic treatment strategies, shaping the future landscape of gastric cancer therapy towards 2030.
Gastric Cancer Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gastric Cancer Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gastric Cancer Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gastric Cancer Therapy industry.
Key market trends defining the global Gastric Cancer Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gastric Cancer Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gastric Cancer Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gastric Cancer Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gastric Cancer Therapy industry
Leading Gastric Cancer Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gastric Cancer Therapy companies.
Gastric Cancer Therapy Market Study- Strategic Analysis Review
The Gastric Cancer Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Gastric Cancer Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gastric Cancer Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gastric Cancer Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gastric Cancer Therapy market segments. Similarly, Strong market demand is encouraging Canadian Gastric Cancer Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gastric Cancer Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gastric Cancer Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gastric Cancer Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gastric Cancer Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gastric Cancer Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gastric Cancer Therapy in Asia Pacific. In particular, China, India, and South East Asian Gastric Cancer Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gastric Cancer Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gastric Cancer Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gastric Cancer Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gastric Cancer Therapy.
Gastric Cancer Therapy Market Company Profiles
The global Gastric Cancer Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, AstraZeneca Plc, Bristol-Myers Squibb Company, Celltrion Healthcare Co. Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Imugene Ltd, Merck & Co. Inc, Novartis AG, Otsuka Holdings Co. Ltd, Pfizer Inc, Sanofi S.A.
Recent Gastric Cancer Therapy Market Developments
The global Gastric Cancer Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gastric Cancer Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
Adenocarcinoma
Lymphoma
Gastrointestinal Stromal Tumor
Carcinoid Tumor
Others
By Treatment
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy and Surgery
By Drug Class
PD-1/PD-L1 Inhibitors
HER2 Antagonists
VEGFR2 Antagonists
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Specialty and Retail Pharmacies
Others
Hospital Pharmacies
Geographical Segmentation:
Amgen Inc
AstraZeneca Plc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Imugene Ltd
Merck & Co. Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A
Formats Available: Excel, PDF, and PPT
The gastric cancer therapy market is undergoing rapid transformation driven by advancements in oncology research, personalized medicine approaches, and evolving treatment paradigms. Gastric cancer remains a significant global health burden, with high morbidity and mortality rates, necessitating continuous innovation in therapeutic strategies. Emerging treatments such as targeted therapies, immune checkpoint inhibitors, and combination regimens are showing promise in improving survival outcomes and quality of life for patients with advanced or metastatic gastric cancer. Further, the integration of genomic profiling, biomarker testing, and liquid biopsy techniques is facilitating precision oncology approaches, enabling tailored treatment decisions based on individual tumor characteristics and patient factors. Additionally, the emphasis on multidisciplinary care, supportive therapies, and patient-centric approaches is driving the development of holistic treatment strategies, shaping the future landscape of gastric cancer therapy towards 2030.
Gastric Cancer Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gastric Cancer Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gastric Cancer Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gastric Cancer Therapy industry.
Key market trends defining the global Gastric Cancer Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gastric Cancer Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gastric Cancer Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gastric Cancer Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gastric Cancer Therapy industry
Leading Gastric Cancer Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gastric Cancer Therapy companies.
Gastric Cancer Therapy Market Study- Strategic Analysis Review
The Gastric Cancer Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Gastric Cancer Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gastric Cancer Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gastric Cancer Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gastric Cancer Therapy market segments. Similarly, Strong market demand is encouraging Canadian Gastric Cancer Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gastric Cancer Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gastric Cancer Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gastric Cancer Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gastric Cancer Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gastric Cancer Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gastric Cancer Therapy in Asia Pacific. In particular, China, India, and South East Asian Gastric Cancer Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gastric Cancer Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gastric Cancer Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gastric Cancer Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gastric Cancer Therapy.
Gastric Cancer Therapy Market Company Profiles
The global Gastric Cancer Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Amgen Inc, AstraZeneca Plc, Bristol-Myers Squibb Company, Celltrion Healthcare Co. Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Imugene Ltd, Merck & Co. Inc, Novartis AG, Otsuka Holdings Co. Ltd, Pfizer Inc, Sanofi S.A.
Recent Gastric Cancer Therapy Market Developments
The global Gastric Cancer Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gastric Cancer Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
Adenocarcinoma
Lymphoma
Gastrointestinal Stromal Tumor
Carcinoid Tumor
Others
By Treatment
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy and Surgery
By Drug Class
PD-1/PD-L1 Inhibitors
HER2 Antagonists
VEGFR2 Antagonists
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Specialty and Retail Pharmacies
Others
Hospital Pharmacies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Amgen Inc
AstraZeneca Plc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Imugene Ltd
Merck & Co. Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Gastric Cancer Therapy Market Overview and Key Findings, 2024
1.2 Gastric Cancer Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Gastric Cancer Therapy Market Growth Opportunities to 2030
1.4 Key Gastric Cancer Therapy Market Trends and Challenges
1.4.1 Gastric Cancer Therapy Market Drivers and Trends
1.4.2 Gastric Cancer Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gastric Cancer Therapy Companies
2. GASTRIC CANCER THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Gastric Cancer Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Gastric Cancer Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GASTRIC CANCER THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GASTRIC CANCER THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Adenocarcinoma
Lymphoma
Gastrointestinal Stromal Tumor
Carcinoid Tumor
Others
By Treatment
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy and Surgery
By Drug Class
PD-1/PD-L1 Inhibitors
HER2 Antagonists
VEGFR2 Antagonists
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Specialty and Retail Pharmacies
Others
Hospital Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gastric Cancer Therapy Market, 2025
5.2 Asia Pacific Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gastric Cancer Therapy Market, 2025
5.5 Europe Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gastric Cancer Therapy Market, 2025
5.8 North America Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gastric Cancer Therapy Market, 2025
5.11 South America Pacific Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gastric Cancer Therapy Market, 2025
5.14 Middle East Africa Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gastric Cancer Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Gastric Cancer Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gastric Cancer Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gastric Cancer Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gastric Cancer Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gastric Cancer Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gastric Cancer Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gastric Cancer Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gastric Cancer Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gastric Cancer Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gastric Cancer Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gastric Cancer Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gastric Cancer Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gastric Cancer Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gastric Cancer Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gastric Cancer Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gastric Cancer Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gastric Cancer Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gastric Cancer Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gastric Cancer Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gastric Cancer Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gastric Cancer Therapy Industry Drivers and Opportunities
7. GASTRIC CANCER THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GASTRIC CANCER THERAPY COMPANY PROFILES
8.1 Profiles of Leading Gastric Cancer Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
AstraZeneca Plc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Imugene Ltd
Merck & Co. Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Gastric Cancer Therapy Market Overview and Key Findings, 2024
1.2 Gastric Cancer Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Gastric Cancer Therapy Market Growth Opportunities to 2030
1.4 Key Gastric Cancer Therapy Market Trends and Challenges
1.4.1 Gastric Cancer Therapy Market Drivers and Trends
1.4.2 Gastric Cancer Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gastric Cancer Therapy Companies
2. GASTRIC CANCER THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Gastric Cancer Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Gastric Cancer Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GASTRIC CANCER THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GASTRIC CANCER THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Adenocarcinoma
Lymphoma
Gastrointestinal Stromal Tumor
Carcinoid Tumor
Others
By Treatment
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy and Surgery
By Drug Class
PD-1/PD-L1 Inhibitors
HER2 Antagonists
VEGFR2 Antagonists
Others
By Route of Administration
Oral
Injectable
By Distribution Channel
Specialty and Retail Pharmacies
Others
Hospital Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gastric Cancer Therapy Market, 2025
5.2 Asia Pacific Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gastric Cancer Therapy Market, 2025
5.5 Europe Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gastric Cancer Therapy Market, 2025
5.8 North America Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gastric Cancer Therapy Market, 2025
5.11 South America Pacific Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gastric Cancer Therapy Market, 2025
5.14 Middle East Africa Gastric Cancer Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gastric Cancer Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gastric Cancer Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Gastric Cancer Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gastric Cancer Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gastric Cancer Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gastric Cancer Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gastric Cancer Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gastric Cancer Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gastric Cancer Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gastric Cancer Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gastric Cancer Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gastric Cancer Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gastric Cancer Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gastric Cancer Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gastric Cancer Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gastric Cancer Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gastric Cancer Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gastric Cancer Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gastric Cancer Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gastric Cancer Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gastric Cancer Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gastric Cancer Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gastric Cancer Therapy Industry Drivers and Opportunities
7. GASTRIC CANCER THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GASTRIC CANCER THERAPY COMPANY PROFILES
8.1 Profiles of Leading Gastric Cancer Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Amgen Inc
AstraZeneca Plc
Bristol-Myers Squibb Company
Celltrion Healthcare Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Imugene Ltd
Merck & Co. Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
